Indeed, the immunohistochemical analysis of the GLS2 level in 112 HCC and 111 adjacent non-tumor tissues (NT) revealed significantly lower GLS2 staining in tumors than in NT tissues; a lack of GLS2 staining correlated with a short survival time [23]. The gene discussed is GLS2; the disease is hepatocellular carcinoma.